These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease. Volloch V; Olsen BR; Rits S Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090 [TBL] [Abstract][Full Text] [Related]
4. AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages. Volloch V; Olsen BR; Rits S Ann Integr Mol Med; 2020; 2(1):75-89. PubMed ID: 32201863 [TBL] [Abstract][Full Text] [Related]
5. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease]. Kowalska A Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529 [TBL] [Abstract][Full Text] [Related]
6. The Y Matrone C; Iannuzzi F; Annunziato L Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414 [TBL] [Abstract][Full Text] [Related]
7. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease]. Xu BG; Wu X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563 [TBL] [Abstract][Full Text] [Related]
8. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. Gandy S; Petanceska S Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430 [TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid, neuronal death and Alzheimer's disease. Carter J; Lippa CF Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259 [TBL] [Abstract][Full Text] [Related]
10. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
11. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease. Takahashi RH; Nagao T; Gouras GK Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941 [TBL] [Abstract][Full Text] [Related]
12. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease. Conway KA; Baxter EW; Felsenstein KM; Reitz AB Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology. Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423 [TBL] [Abstract][Full Text] [Related]
14. What Do Recent Clinical Trials Teach Us About the Etiology of AD. Robakis NK Adv Exp Med Biol; 2020; 1195():167. PubMed ID: 32468473 [TBL] [Abstract][Full Text] [Related]
15. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease. Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133 [TBL] [Abstract][Full Text] [Related]
16. The antimicrobial protection hypothesis of Alzheimer's disease. Moir RD; Lathe R; Tanzi RE Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800 [TBL] [Abstract][Full Text] [Related]
17. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models. Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942 [TBL] [Abstract][Full Text] [Related]